Analysis of clinical factors as possible predictors of response to omalizumab and relapse after treatment discontinuation in chronic spontaneous urticaria-Reference-Cited by-同舟云学术

Analysis of clinical factors as possible predictors of response to omalizumab and relapse after treatment discontinuation in chronic spontaneous urticaria

Published:2021-12-16 Issue:2 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Foti Caterina¹,Romita Paolo¹^ORCID,Ambrogio Francesca¹,Fanelli Margherita²,Panebianco Rosanna¹,Vena Gino Antonio³,Cassano Nicoletta³,Ragusa Mariagrazia¹,Giuffrida Roberta⁴^ORCID,Papaianni Valeria⁴,Borgia Francesco⁴^ORCID,Cannavò Serafinella Patrizia⁴,Guarneri Fabrizio⁴

Affiliation:

1. Department of Biomedical Science and Human Oncology, Section of Dermatology University of Bari Bari Italy

2. Department of Interdisciplinary Medicine “Aldo Moro” University of Bari Bari Italy

3. Dermatology and Venereology Private Practice Bari Italy

4. Department of Clinical and Experimental Medicine ‐ Dermatology University of Messina Messina Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15248

Reference23 articles.

1. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

2. Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology

3. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1

4. Management of Chronic Spontaneous Urticaria in the Elderly

5. Epidemiology, healthcare, resources, use and clinical features of different types of urticaria;Ferrer M;J Investig Allergol Clin Immunol,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atopy and Response to Omalizumab Treatment in Chronic Spontaneous Urticaria;International Archives of Allergy and Immunology;2023-12-19

2. Omalizumab Drug Survival in Chronic Urticaria: A Retrospective Multicentric French Study;The Journal of Allergy and Clinical Immunology: In Practice;2023-12

3. Association Between Serum Total IgE Levels and Clinical Response to Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis;The Journal of Allergy and Clinical Immunology: In Practice;2023-08

4. Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know;American Journal of Clinical Dermatology;2023-02-22

5. Sex, Allergic Diseases and Omalizumab;Biomedicines;2022-01-29